EVERTREE BIO
Live / Allowed — Notice of allowance issued (as of 03 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 21 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99195603
- Mark type
- Stylized text
- Filed
- 21 May 2025
- Published for opposition
- 06 Jan 2026
- Attorney of record
- Ozelle Martin
Goods and services
- Class 001 — Chemicals: Chemical preparations for medical purposes, namely, cells for medical research in the form of cell growth media for growing cells for scientific and research use in the field of neurological and cardiovascular tissue engineering
- Class 005 — Pharmaceuticals: Chemical preparations for pharmaceutical or medical purposes, namely, for neurological diseases
- Class 042 — Scientific and technological services: Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields
Owner
- INNERVENE, INC., San Francisco, CA, US
- INNERVENE, INC., San Francisco, CA, US
Prosecution history
- 03 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Jan 2026 — PUBLISHED FOR OPPOSITION
- 31 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Dec 2025 — EXAMINER'S AMENDMENT ENTERED
- 04 Dec 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 04 Dec 2025 — EXAMINERS AMENDMENT E-MAILED
- 04 Dec 2025 — EXAMINERS AMENDMENT -WRITTEN
- 19 Nov 2025 — ASSIGNED TO EXAMINER
- 14 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 10 Oct 2025 — NON-FINAL ACTION E-MAILED